ANSELL LIMITED (ANN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ANN

ANN - ANSELL LIMITED

FNArena Sector : Commercial Services & Supplies
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 2.27
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Ansell is an Australian manufacturer of protective industrial equipment and household and medical gloves. It is the remnant of Pacific Dunlop, once a mighty conglomerate that listed in 1985. The name was changed to Ansell in 2002.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$28.12

24 Mar
2026

0.130

OPEN

$28.38

0.46%

HIGH

$28.49

555,046

LOW

$28.00

TARGET
$35.458 26.1% upside
OTHER COMPANIES IN THE SAME SECTOR
AIM . ASB . CUP . DGL . IMB . KPG . RDX . SRV .
FNARENA'S MARKET CONSENSUS FORECASTS
ANN: 1
Title FY26
Forecast		 FY27
Forecast
EPS (cps) 215.3 xxx
DPS (cps) 93.7 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 13.3 xxx
Dividend Yield 3.3% xxx
Div Pay Ratio(%) 43.5% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 2.71%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 2.51

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 14/02 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx108.0
DPS All xxxxxxxxxxxxxxx77.7
Sales/Revenue xxxxxxxxxxxxxxx3,093.3 M
Book Value Per Share xxxxxxxxxxxxxxx2,053.0
Net Operating Cash Flow xxxxxxxxxxxxxxx306.2 M
Net Profit Margin xxxxxxxxxxxxxxx5.07 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx5.38 %
Return on Invested Capital xxxxxxxxxxxxxxx3.87 %
Return on Assets xxxxxxxxxxxxxxx3.16 %
Return on Equity xxxxxxxxxxxxxxx5.38 %
Return on Total Capital xxxxxxxxxxxxxxx10.16 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx100.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx124 M
Long Term Debt xxxxxxxxxxxxxxx1,106 M
Total Debt xxxxxxxxxxxxxxx1,229 M
Goodwill - Gross xxxxxxxxxxxxxxx2,253 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx364 M
Price To Book Value xxxxxxxxxxxxxxx1.48

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx107.0 M
Capex % of Sales xxxxxxxxxxxxxxx3.46 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,826 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx840 M
Research & Development xxxxxxxxxxxxxxx32 M
Investments - Total xxxxxxxxxxxxxxx6 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

17/02/2026

3

Hold

$35.23

25.28%

Ansell's first half result was stronger than it first appeared, Morgans asserts, as expanding margins produced profit above expectations despite soft topline growth.

Tariff-related pricing appears to be working so far and the company is continuing to execute well on acquisitions and cost savings.

FY26 adjusted EPS guidance of US$1.37-49 has been maintained, which implies for the broker a modest underlying improvement.

Still, with organic momentum slowing, tariff uncertainty and the digitisation risks that are ahead, Morgans maintains a Hold rating. Target is raised to $35.23 from $34.64.

FORECAST
Morgans forecasts a full year FY26 dividend of 95.40 cents and EPS of 216.53 cents.
Morgans forecasts a full year FY27 dividend of 104.48 cents and EPS of 234.71 cents.

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

ANN STOCK CHART

FNArena News on ANN

1
Rudi’s View: Make Today’s Crisis Your Opportunity

Mar 25 2026 - Rudi's View
2
FNArena Corporate Results Monitor – 17-02-2026

Feb 17 2026 - Australia
3
Rudi’s View: February Favourites & Avoids

Jan 29 2026 - Rudi's View
4
Rudi’s View: ALS, Bega, Coles, Elders, Light & Wonder, Lovisa, Telix & More

Oct 23 2025 - Rudi's View
5
Rudi’s View: In Corporate Earnings We Must Trust

Oct 22 2025 - Rudi's View

Latest Commercial Services & Supplies News

1
Fortress Australia: Identifying The ‘Real’ Beneficiaries Of The $330bn Defence Pipeline

Mar 23 2026 - Small Caps
2
Market Concerns Eclipse NextDC’s Growth Outlook

Mar 13 2026 - Australia
3
WiseTech Juggling AI Risks And Growth Levers

Mar 11 2026 - Australia
4
Dicker Data Counts On IT Spending, Data Centres

Mar 09 2026 - Small Caps
5
Life360, Growth Deferred Or Denied?

Mar 05 2026 - Australia
6
Rudi’s View: Is Higher Volatility Now A Permanent Feature?

Feb 18 2026 - Rudi's View
7
Treasure Chest: WiseTech Global

Feb 10 2026 - Treasure Chest
8
The Great Capex Catch-Up: When Infrastructure Pipelines Meet a Commodity Gale

Feb 10 2026 - Australia
9
ALS Shares Resuming Uptrend

Feb 10 2026 - Technicals
10
Is AI Nemesis Or Opportunity For Xero?

Feb 05 2026 - Australia